Cite

HARVARD Citation

    Poosti, F. et al. (2022). Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide. Clinical & translational immunology. 11 (2), p. n/a. [Online]. 
  
Back to record